From the May 2002 Idaho Observer:
Vaccine packet inserts: How to read between the lines
by Ingri Cassel
Before a vaccine or any type of injection is administered, it is your right and responsibility to read the packet insert provided by the manufacturer. Or, better yet, go to the manufacturer's website before seeing your physician and write down some pertinent information with a series of questions to address to the attending nurse. Make sure you are also prepared with a form for them to sign (see page 14), relieving you of the financial burden you may endure should you have any adverse reaction, immediate or delayed, as a result of the injection. Just to give you a taste of what you will find on a particular vaccine on the manufacturer's website, I decided to go to Aventis Pasteur's website: www.us.aventispasteur.com/PRODUCT/Default.cfm
Under Haemophilus b is listed a vaccine registered as ActHIB®. It is described a Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate). We are immediately told that, federal law prohibits administration without a prescription.
Are school districts, daycares and employers practicing medicine without a license by telling you that you must get a prescription to a particular vaccine?
Under Adverse Reactions on page 5 of 9 pages, we are told that, More than 7,000 infants and young children (two years of age or less) have received at least one dose of ActHIB® during U.S. clinical trials. Of these, 1,064 subjects 12-24 months of age who received ActHIB® alone reported no serious or life threatening adverse reactions.
This means that 15 percent of the 7,000 young children did not have a serious adverse reaction to ActHIB® when administered alone. From the charts listed on page 6 and 7, it can be deduced that all infants under 12 months of age experienced adverse reactions ranging from tenderness and induration (hardening of tissue) at the injection site to systemic reactions such as fever, drowsiness and irritability.
It is also worth noting that these clinical studies only observe their subjects for 48 hours after the injection is administered. For those familiar with monitoring adverse reactions, most severe reactions tend to occur between 9 to 11 days following the injection(s). Also, rarely are vaccines administered singly. Most doctors are not aware of the studies conducted that contraindicate the administration of several vaccines during one doctor visit. It is the Centers for Disease Control and Prevention and sales representatives for the pharmaceutical industry that provide the educational material doctors use in their offices. We have found that their literature is often filled with claims that do not withstand scientific scrutiny, otherwise known as lies.
On page 8 are the instructions for administering ActHIB®. In all capital letters they state, DO NOT INJECT INTRAVENOUSLY and then continue with, Each dose of ActHIB® is administered intramuscularly in the outer aspect of the vastus lateralis (mid-thigh) or deltoid. The vaccine should not be injected into the gluteal area or areas where there may be a nerve trunk. During the course of primary immunizations, injections should not be made more than once at the same site.
How do we know if the nurse has read these instructions or is experienced in administering the vaccine properly? What could happen if the vaccine was administered improperly?
Further down on page 8, the physician is told how to reconstitute and store ActHIB® with whole-cell DTP or with .4 percent sodium chloride diluent. These two added ingredients as a means of reconstituting ActHIB® contain preservatives but are not mentioned as to what they are. Formaldehyde, thimerosal (ethyl mercury) and aluminum hydroxide are all commonly used as preservatives in most vaccines. The physician is then told that once ActHIB® is reconstituted, it must be administered within 24 hours and stored at a temperature 35° to 46° F.
Again, how do we know that the doctor's office is taking the proper precautions in handling this virulent product? And when one looks at the inadequate testing done on the vaccine to get it licensed, do you really feel this product is as safe as the doctor has assured you it is? Safety is not even a factor in getting the product licensed. What counts is simply proof that the vaccine to be licensed produces a certain amount of specific antibodies in the subjects tested. In fact, the vaccine that causes the highest amount of antibody production it is considered to be a sign that is the most effective of the vaccines tested.
When one realizes that high antibody production actually correlates to a weakened immune system, it makes one wonder how this scam ever got such a strong hold in people's minds in the first place.
Home - Current Edition
Advertising Rate Sheet
About the Idaho Observer
Some recent articles
Some older articles
Why we're here
Corrections and Clarifications
Vaccination Liberation - vaclib.org
We have traditionally relied on experts to make decisions regarding what goes into our bodies. If we attempt to question the safety and efficacy of certain prescribed substances, we are assaulted with a barrage of technical/medical jargon. The intent of such verbiage is to encourage surrendering our authority to experts where our health is concerned. We can no longer afford to be cowed by such estimated expertise -- the lifelong health and wellbeing of our children hangs in the balance. Step one is to follow your instincts as a parent. It is natural to be concerned that the injection of known toxins and animal pus may not be good for your child. Step two is to take a look at the packet inserts for vaccines (or any pharmaceutical drug) and do the math. Step three is to politely demand answers from the physician and postpone medication until the questions have been answered to your satisfaction. Always remember that the future of your child hangs in the balance and the vaccinator will not have to live with your decision -- unless they accept liability.
The Idaho Observer
P.O. Box 457
Spirit Lake, Idaho 83869